Cas:1256345-66-0 6-Chloro-2-fluoropyridine-3-boronic acid manufacturer & supplier

Chemical Name:6-Chloro-2-fluoropyridine-3-boronic acid

CAS.NO:1256345-66-0

Synonyms:6-Chloro-2-fluoropyridine-3-boronic acid;(6-Chloro-2-fluoro-3-pyridinyl)boronic acid;Boronic acid, B-(6-chloro-2-fluoro-3-pyridinyl)-;(6-Chloro-2-fluoropyridin-3-yl)boronic acid

Molecular Formula:C₅H₄BClFNO₂

Molecular Weight:175.353

HS Code:2933399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:341.4±52.0 °C at 760 mmHg

Density:1.5±0.1 g/cm3

Index of Refraction:1.533

PSA:53.35000

Exact Mass:175.000763

LogP:0.44

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 6-Chloro-2-fluoropyridine-3-boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(6-Chloro-2-fluoropyridin-3-yl)boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-Chloro-2-fluoropyridine-3-boronic acid Use and application,(6-Chloro-2-fluoro-3-pyridinyl)boronic acid technical grade,usp/ep/jp grade.

Related News: The company��s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments. 6-Chloro-2-fluoropyridine-3-boronic acid manufacturer Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS. 6-Chloro-2-fluoropyridine-3-boronic acid supplier ICIG has agreed to offer employment to the unit��s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland. 6-Chloro-2-fluoropyridine-3-boronic acid vendor In its message to the public, the FDA said that a person should consider being retested if they used Innova’s diagnostic within the past two weeks. 6-Chloro-2-fluoropyridine-3-boronic acid factory The company��s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.